This report explores the evolving management of early esophageal adenocarcinoma (EAC), focusing on the therapeutic balance between endoscopic resection and esophagectomy. It synthesizes recent evidence from international guidelines, surgical and endoscopic series, and predictive modeling studies to clarify lymph-node metastasis (LNM) risk, evaluate current staging limitations, and discuss future directions in treatment stratification and personalized care.
Giorgi et al. (Tue,) studied this question.